Fig. 2From: Prevalence of BRCA1 and BRCA2 pathogenic and likely pathogenic variants in non-selected ovarian carcinoma patients in BrazilFrequency of pathogenic or likely pathogenic variants in BRCA1 and BRCA2 according to clinical characteristicsBack to article page